drugset / Trial / NCT06669091

Food-effect Study of Ecopipam Pharmacokinetics

NCT06669091

Phase 1 Completed 25 enrolled Emalex Biosciences Inc.
RandomizedCrossoverOpen-labelBasic science

Summary

Standard food-effect study to identify the effect of food on ecopipam pharmacokinetics after administration of a to-be-marketed ecopipam tablet in healthy volunteers.

Timeline

Start
2024-11-05
Primary completion
2024-12-22
Completion
2024-12-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Ecopipam Small molecule 89.6 mg

Indications

No indication recorded.